The Impact of Leaving Group Variation on the Anticancer Activity of Molybdenocenes-Reference-Cited by-同舟云学术

The Impact of Leaving Group Variation on the Anticancer Activity of Molybdenocenes

Published:2018-10-22 Issue:21 Volume:37 Page:3909-3916
ISSN:0276-7333
Container-title:Organometallics
language:en
Short-container-title:Organometallics

Author:

Kandioller Wolfgang^ORCID,Reikersdorfer Marlene,Theiner Sarah^ORCID,Roller Alexander,Hejl Michaela,Jakupec Michael A.,Malarek Michael S.^ORCID,Keppler Bernhard K.

Funder

Universit?t Wien

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.organomet.8b00582

Reference33 articles.

1. Metallocenes as target specific drugs for cancer treatment

2. Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics

3. Organometallic Anticancer Compounds

4. Titanocene Dichloride-The First Metallocene with Cancerostatic Activity

5. Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidation states in metallocenes: A key mechanistic component in cancer alleviation;Coordination Chemistry Reviews;2024-04

2. A C-PCM Outlook of Structural and Spectroscopic (IR, 1H NMR) Properties of [Cp2Mo(6-mercaptopurine)]Cl Complex;Chemistry Africa;2024-02-20

3. Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models;Pharmaceutics;2023-07-03

4. Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design;New Journal of Chemistry;2023

5. Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice;Chemistry – A European Journal;2022-11-29